News
Vibalogics appoints global CEO to lead U.S. expansion
Vibalogics, a global contract development and manufacturing organization (CDMO) that specializes in the production of virotherapy products, has announced the appointment of Tom Hochuli as...
News
Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68...
Intravacc, a global provider of translational research and development of viral and bacterial vaccines, has been awarded a contract with base and options that may...
News
Cipla Health ventures into antifungal product category with launch...
Cipla Health Ltd., a leading consumer healthcare brand, has forayed into the antifungal product category with the introduction of Clocip, to offer a hardworking skin...
News
Roche announces FDA approval of Gavreto for the treatment...
Roche announced that the United States (US) FDA has approved Gavretoâ„¢ (pralsetinib) for the treatment of adults with metastatic rearranged during transfection (RET) fusion-positive non-small...
Clinical Trials
Merck announces positive results phase 3 trials of gefapixant...
Merck, known as MSD outside the United States and Canada, has announced the results from two pivotal phase 3 trials (COUGH-1 and COUGH-2) evaluating the...
News
Mylan to Acquire Aspen’s Thrombosis Business in Europe
Mylan N.V. announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe for EUR...
News
Bayer completes acquisition of UK-based biotech company KaNDy Therapeutics...
Bayer, a global leader in women’s healthcare, announced that, further to its press release of August 11, 2020, it has now completed the acquisition of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.